Hematology:
Changes in WBCs, RBCs, Hb, hematocrit, MCV, platelets, neutrophils, eosinophils, monocytes and lymphocytes were evaluated. Induction of alloxan increased in WBCs, hematocrit, platelets and neutrophils and decreased in RBCs, Hb, MCV and lymphocytes significantly. Treatment with BLR extract and glibenclamide revesed most of these changes significantly. All other changes were non-significant (figure 8a and 8b